Insulin NPH is an intermediate-acting insulin used to manage blood sugar levels for individuals with diabetes. It is characterized by its cloudy appearance, distinguishing it from clear, rapid-acting insulins.
How quickly does Insulin NPH start working?
Insulin NPH typically begins to lower blood glucose levels within 1 to 3 hours after injection. Its peak effect, when it is most potent, occurs between 6 to 10 hours, and its action can last for 10 to 16 hours [1].
What is the difference between Insulin NPH and other insulins?
Unlike rapid-acting insulins (e.g., lispro, aspart, glulisine) which begin working within 15 minutes, or long-acting insulins (e.g., glargine, detemir, degludec) that provide a steady effect for up to 24 hours or more, Insulin NPH has an intermediate duration of action. This means it provides coverage for a significant portion of the day or night but requires careful timing with meals and potentially multiple daily injections for comprehensive blood sugar control [1]. Its cloudy nature is due to the addition of protamine, a protein that slows its absorption compared to clear insulins.
When does Insulin NPH patent protection expire?
Information regarding the specific patent expiry dates for Insulin NPH is often complex due to its long history and potential for multiple patents covering manufacturing processes, formulations, and delivery devices. DrugPatentWatch.com tracks patent data, which can indicate when market exclusivity may end [2].
Who makes Insulin NPH?
Several pharmaceutical companies manufacture and distribute Insulin NPH under various brand names. Common examples include Humulin N KwikPen and Novolin N, produced by Eli Lilly and Company and Novo Nordisk, respectively [1].
What are the potential side effects of Insulin NPH?
The most common side effect of Insulin NPH, like all insulins, is hypoglycemia, or low blood sugar. Symptoms can include shakiness, sweating, confusion, dizziness, and rapid heartbeat. Other potential side effects can involve injection site reactions such as redness, swelling, or itching, and in some cases, lipodystrophy (changes in fat tissue at the injection site) [1].
Can Insulin NPH be mixed with other insulins?
Insulin NPH can often be mixed with rapid-acting insulins in the same syringe. This allows for a combination of quick and intermediate coverage. However, it is crucial to follow specific mixing instructions provided by a healthcare professional or the insulin manufacturer, as the order of drawing up the insulins and the type of insulin can be critical to avoid altering their effectiveness [1].
What are the storage and handling requirements for Insulin NPH?
Unopened vials or pens of Insulin NPH should be stored in the refrigerator. Once opened, vials or pens can typically be stored at room temperature for a limited period, usually around 28 days, and should be protected from direct heat and light. It is important to avoid freezing Insulin NPH [1].
How is Insulin NPH administered?
Insulin NPH is administered via subcutaneous injection, meaning it is injected into the fatty tissue just under the skin. Common injection sites include the abdomen, thighs, buttocks, or upper arms [1].
Sources:
1. https://www.drugpatentwatch.com/drug/insulin-nph
2. https://www.drugpatentwatch.com/